Abstract
A murine mammary carcinoma, which had a high potential for metastasis to the lungs, was established in culture, and from the parent line several clonally derived variants were isolated, showing different characteristics including metastatic potential. C1, a high metastatic clone, and C2, a low one, were selected for further study. When tumour cells were injected s.c. the growth rates of the resulting tumours were higher when they developed from the parent line (P2) or C1 cells, than from C2 cells. The numbers of lung colonies seen following i.v. inoculation of tumour cells also varied, C2 cells yielding the lowest score.In vitro C1 cells were more efficient at aggregating platelets than C2, an effect reduced by the addition of heparin.In vivo heparin reduced the number of tumour cells arrested in the lungs after i.v. injection, and also the number lung colonies which subsequently became established. The number of metastases which developed following s.c. injection of tumour cells was also reduced by heparin.
Similar content being viewed by others
References
Ambrus, J. L., Ambrus, C. M., andGastpar, H., 1978, Studies on platelet aggregation and platelet interaction with tumour cells.Platelets: A Multidisciplinary Approach, edited by G. de Gaetano and S. Garattini (New York: Raven Press), pp. 467–480.
Camez, A., Dupuy, E., Bellucci, S., Calvo, F., Bryckaert, M. C., andTobelem, G., 1986, Human platelet-tumor cell interactions vary with the tumor cell lines.Invasion and Metastasis,6, 321–334.
Donati, M. B., 1984, Hemostatic abnormalities in tumour-bearing animals.Hemostatic Mechanisms and Metastasis, edited by K. V. Honn and B. F. Sloane (Boston: Martinus Nijhoff), pp. 62–71.
Estrada, J., andNicolson, G. L., 1984, Tumour-cell-platelet aggregation does not correlate with metastatic potential of rat 13762NF mammary adenocarcinoma tumor cell clones.International Journal of Cancer,34, 101–105.
Gasic, G. J., Gasic, T. B., andStewart, C. C., 1968, Antimetastatic effects associated with platelet reduction.Proceedings of the National Academy of Sciences, U.S.A.,61, 46–52.
Gasic, G. J., Gasic, T. B., Galanti, N., Johnson, T., andMurphy, S., 1973, Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease.International Journal of Cancer,11, 704–718.
Glaves, D., 1986, Intravascular death of disseminated cancer cells mediated by Superoxide anion.Invasion and Metastasis,6, 101–111.
Gorelik, E., Bere, W. W., andHerberman, R. B., 1984, Role of NK cells in the antimetastatic effect of anticoagulant drugs.International Journal of Cancer,33, 87–94.
Grignani, G., Almasio, P., Pacchiarini, L., Ricetti, M. M., Serra, L., andGamba, G., 1983, Interactions between neoplastic cells with different metastasizing capacity and platelet function.European Journal of Cancer and Clinical Oncology,4, 519–525.
Grignani, G., Pacchiarini, L., Almasio, P., Pagliarino, M., Gamba, G., Rizzo, S. C., andAscari, E., 1986, Characterization of the platelet-aggregating activity of cancer cells with different metastatic potential.International Journal of Cancer,38, 237–244.
Hart, I. R., 1982, ‘Seed and soil’ revisited: mechanisms of site-specific metastasis.Cancer Metastasis Reviews,1, 5–16.
Honn, K. V., 1983, Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin thromboxane A2 system.Clinical and Experimental Metastasis,1, 103–114.
Honn, K. V., Cicone, B., andSkoff, A., 1981, Prostacyclin: a potent antimetastatic agent.Science,212, 1270–1272.
Honn, K. V., Menter, D. G., Onoda, J. M., Taylor, J. D., andSloane, B. F., 1984, Role of prostacyclins as a natural deterrent to hematogenous tumour metastasis.Cancer Invasion and Metastasis: Biologic and Therapeutic Aspects, edited by G. L. Nicolson and L. Milas (New York: Raven Press), pp. 361–388.
Karpatkin, S., andPearlstein, E., 1984, Heterogenous mechanisms of tumour cell-induced platelet aggregation with possible pharmacologic strategy toward prevention of metastases.Hemostatic Mechanisms and Metastasis, edited by K. V. Honn and B. F. Sloane (Boston: Martinus Nihhoff), pp. 139–169.
Lampugnani, M. G., andCrawford, N., 1987, Tumour-cell-induced platelet aggregation: studies with cloned metastatic and non-metastatic variants.Invasion and Metastasis,7, 311–324.
Lee, A. E., Pang, L. S. C., Rogers, L. A., andJeffery, R. E., 1983, Metastasis of mammary tumours in mice: relationship with morphology of primary tumour, and reproductive background of host.Clinical and Experimental Metastasis,1, 223–227.
Lerner, W. A., Pearlstein, E., Amrogio, C., andKarpatkin, S., 1983, A new mechanism for tumor-induced platelet aggregation, comparison with mechanisms shared by other tumors with possible pharmacologic strategy toward prevention of metastases.International Journal of Cancer,31, 463–469.
Lichtner, R. B., Hutchinson, G., Wedderburn, N., andHellmann, K., 1985, Antiplatelet pyrimido-pyrimidines and metastasis,Cancer Treatment Reviews,12, 221–234.
Maat, B., andHilgard, P., 1981, Anticoagulants and experimental metastases-evaluation of antimetastatic effects in different model systems.Journal of Cancer Research and Clinical Oncology,101, 275–283.
Menter, D. G., Onoda, J. M., Taylor, J. D., andHonn, K. V., 1984, Effects of prostacyclin on tumor cell-induced platelet aggregation.Cancer Research,44, 450–456.
Millar, R. C., andKetcham, A. S., 1974, The effect of heparin and warfarin on primary and metastatic tumors.Journal of Medicine,5, 23–31.
Pearlstein, E., Salk, P. L., Yogeswaran, G., andKarpatkin, S., 1980, Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line.Proceedings of the National Academy of Sciences, U.S.A.,77, 4336–4339.
Peters, G., Lee, A. E., andDickson, C., 1986, Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus.Nature,320, 628–631.
Regelson, W., 1968, The growth-regulating activity of polyanions: a theoretical discussion of their place in the intercellular environment and their role in cell physiology.Advances in Cancer Research,11, 223–304.
Steiner, M., 1982, Interaction of platelets and tumour cells.Interaction of Platelets and Tumour Cells, edited by G. A. Jamieson (New York: Alan Liss), pp. 383–403.
Stringfellow, D. A., 1984, Prostaglandins and metastasis.Cancer Invasion and Metastasis: Biologic and Therapeutic Aspects, edited by G. L. Nicolson and L. Milas (New York: Raven Press), pp. 123–131.
Tohgo, A., Tanaka, N. G., andOgawa, H., 1986, Platelet-aggregating activities of metastasizing tumor cells.Invasion and Metastasis,6, 58–68.
Tuszynski, G. P., Gasic, T. B., Rothman, V. L., Knudsen, K. A., andGasic, G. J., 1987, Thrombospondin, a potentiator of tumor cell metastasis.Cancer Research,47, 4130–4133.
Yamamura, Y., Braunschweiger, P. G., Madyastha, K. R., andProctor, J. W., 1984, Immunological responses to a murine mammary adenocarcinoma. Outgrowth of pulmonary occult metastases induced by immunosuppressive perturbations.International Journal of Cancer,33, 73–77.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, A.E., Rogers, L.A., Jeffery, R.E. et al. Comparison of metastatic cell lines derived from a murine mammary tumour, and reduction of metastasis by heparin. Clin Exp Metast 6, 463–471 (1988). https://doi.org/10.1007/BF01784377
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01784377